<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02575729</url>
  </required_header>
  <id_info>
    <org_study_id>NMRPG8A0051</org_study_id>
    <nct_id>NCT02575729</nct_id>
  </id_info>
  <brief_title>Sonography-guided Steroid Injection for Carpal Tunnel Syndrome</brief_title>
  <official_title>Sonography-guided Steroid Injection for Carpal Tunnel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chang Gung Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To compare the outcome between sonography-guided steroid injection and direct
      steroid injection on carpal tunnel syndrome(CTS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Material and methods: We have enrolled 26 ideopathic carpal tunnel syndrome patients (minimal
      to moderate according to Padua's classification).Thirteen patients were allocated in
      sonography approach group( sonography-guided local wrist injection, SAG) and the 13 patients
      were placed in direct approach group(direct local injection without using sonography, DAG).
      One , 3 and 6 months later after injection, we performed the outcome measures, including
      Boston symptom and functional scale, QuickDASH, nerve conduction study and sonography. If the
      patients receive the second injections, we will follow their treatment outcome by phone
      regularly at 1,3 and 6 months after first injection. If the patients were referred to
      surgery, the failures of local injection were considered and we will stop follow up them.
      After performing all assessment, we will compare the outcomes between the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2011</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>QuickDASH</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chinese version of Boston symptom and function scale for carpal tunnel syndrome, SS &amp; FS</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Record the neurological symptoms perceived by patient after injection according to their describtion</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Semmes-Weinstein Monofilament test(SWMT)</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2-Point Discrimination test on 2nd digit</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nerve conduction study done on the affected hand using Necolet Viking Quest</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
    <description>We will record the latency, amplitude and conduction velocity retrieved from nerve conduction study of both motor neurons and sensory neuron</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sonography examination done with patients sitting, elbow flexion and forearm supination placing on table</measure>
    <time_frame>Change from Baseline data at 6 weeks</time_frame>
    <description>The test will done twice and will record the average data of both the cross-section area and the bowing distance of transverse ligament of wrist.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Carpal Tunnel Syndrome(CTS)</condition>
  <arm_group>
    <arm_group_label>Inject betamethasone by sonography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use 5/8 in medical needles inject betamethasone 7mg (1ml) in distal wrist crease by sonography- guided. Entering skin with 30 degrees from the ulnar side of palmaris longus tandon. Changing direction of injection to prevent median nerve injury if patients feel numbness or pain in hand.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inject betamethasone directly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use 5/8 in medical needles inject betamethasone 7mg (1ml) in distal wrist crease directly. Entering skin with 30 degrees from the ulnar side of palmaris longus tandon. Changing direction of injection to prevent median nerve injury if patients feel numbness or pain in hand.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>betamethasone</intervention_name>
    <description>Inject betamethasone on the wrist for patient with carpal tunnel syndrome with sonography- guided, directly.</description>
    <arm_group_label>Inject betamethasone by sonography</arm_group_label>
    <arm_group_label>Inject betamethasone directly</arm_group_label>
    <other_name>glucocorticoid preparation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  with &gt;2 following symptoms :

               1. disrupt sleep result in nocturnal paresthesia.

               2. symptoms release by shaking hand.

               3. pain and paresthesia during grasping.

               4. any sensory symptom on first, 2th, 3th and partial 4th fingers.

          -  symptoms &gt;1month.

          -  Padua's classification : minimal, mild, moderate)

          -  meet one of three diagnosis criteria of carpal tunnel syndrome.

        Exclusion Criteria:

          -  any history can cause periphery nerve disease.

          -  affected side had fracture or paralysis.

          -  had accepted operation for carpal tunnel syndrome before.

          -  pregnant

          -  wrist or hand sprain, ulnar nerve disease cervical nerve root disease, multiple
             neuropathy or nerve anastomosis.

          -  Padua's classification: severe, extreme.

          -  ultrasonography show space occupying.

          -  patient taking anticoagulants.

          -  severe systemic disease.

          -  wrist's skin or wrist joint has infection.

          -  can't complete the 6 months' follow up.

          -  allergy to steroid.

          -  has cognition disorder.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pong Ya-Ping, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Rehabilitation</affiliation>
  </overall_official>
  <reference>
    <citation>Premoselli S, Sioli P, Grossi A, Cerri C. Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-months clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Eura Medicophys. 2006 Jun;42(2):121-6.</citation>
    <PMID>16767058</PMID>
  </reference>
  <reference>
    <citation>Armstrong T, Devor W, Borschel L, Contreras R. Intracarpal steroid injection is safe and effective for short-term management of carpal tunnel syndrome. Muscle Nerve. 2004 Jan;29(1):82-8.</citation>
    <PMID>14694502</PMID>
  </reference>
  <reference>
    <citation>Dammers JW, Veering MM, Vermeulen M. Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ. 1999 Oct 2;319(7214):884-6.</citation>
    <PMID>10506042</PMID>
  </reference>
  <reference>
    <citation>Jarvik JG, Comstock BA, Kliot M, Turner JA, Chan L, Heagerty PJ, Hollingworth W, Kerrigan CL, Deyo RA. Surgery versus non-surgical therapy for carpal tunnel syndrome: a randomised parallel-group trial. Lancet. 2009 Sep 26;374(9695):1074-81. doi: 10.1016/S0140-6736(09)61517-8.</citation>
    <PMID>19782873</PMID>
  </reference>
  <reference>
    <citation>Irvine J, Chong SL, Amirjani N, Chan KM. Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome. Muscle Nerve. 2004 Aug;30(2):182-7.</citation>
    <PMID>15266633</PMID>
  </reference>
  <reference>
    <citation>Oztas O, Turan B, Bora I, Karakaya MK. Ultrasound therapy effect in carpal tunnel syndrome. Arch Phys Med Rehabil. 1998 Dec;79(12):1540-4.</citation>
    <PMID>9862296</PMID>
  </reference>
  <reference>
    <citation>Weintraub MI, Cole SP. A randomized controlled trial of the effects of a combination of static and dynamic magnetic fields on carpal tunnel syndrome. Pain Med. 2008 Jul-Aug;9(5):493-504.</citation>
    <PMID>18777606</PMID>
  </reference>
  <reference>
    <citation>Breuer B, Sperber K, Wallenstein S, Kiprovski K, Calapa A, Snow B, Pappagallo M. Clinically significant placebo analgesic response in a pilot trial of botulinum B in patients with hand pain and carpal tunnel syndrome. Pain Med. 2006 Jan-Feb;7(1):16-24.</citation>
    <PMID>16533192</PMID>
  </reference>
  <reference>
    <citation>Chang MH, Chiang HT, Lee SS, Ger LP, Lo YK. Oral drug of choice in carpal tunnel syndrome. Neurology. 1998 Aug;51(2):390-3.</citation>
    <PMID>9710008</PMID>
  </reference>
  <reference>
    <citation>Hui AC, Wong SM, Wong KS, Li E, Kay R, Yung P, Hung LK, Yu LM. Oral steroid in the treatment of carpal tunnel syndrome. Ann Rheum Dis. 2001 Aug;60(8):813-4.</citation>
    <PMID>11482310</PMID>
  </reference>
  <reference>
    <citation>Wong SM, Hui AC, Tang A, Ho PC, Hung LK, Wong KS, Kay R, Li E. Local vs systemic corticosteroids in the treatment of carpal tunnel syndrome. Neurology. 2001 Jun 12;56(11):1565-7.</citation>
    <PMID>11402116</PMID>
  </reference>
  <reference>
    <citation>Piazzini DB, Aprile I, Ferrara PE, Bertolini C, Tonali P, Maggi L, Rabini A, Piantelli S, Padua L. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil. 2007 Apr;21(4):299-314. Review.</citation>
    <PMID>17613571</PMID>
  </reference>
  <reference>
    <citation>Huisstede BM, Hoogvliet P, Randsdorp MS, Glerum S, van Middelkoop M, Koes BW. Carpal tunnel syndrome. Part I: effectiveness of nonsurgical treatments--a systematic review. Arch Phys Med Rehabil. 2010 Jul;91(7):981-1004. doi: 10.1016/j.apmr.2010.03.022. Review.</citation>
    <PMID>20599038</PMID>
  </reference>
  <reference>
    <citation>Sevim S, Dogu O, Camdeviren H, Kaleagasi H, Aral M, Arslan E, Milcan A. Long-term effectiveness of steroid injections and splinting in mild and moderate carpal tunnel syndrome. Neurol Sci. 2004 Jun;25(2):48-52.</citation>
    <PMID>15221621</PMID>
  </reference>
  <reference>
    <citation>Kasten SJ, Louis DS. Carpal tunnel syndrome: a case of median nerve injection injury and a safe and effective method for injecting the carpal tunnel. J Fam Pract. 1996 Jul;43(1):79-82.</citation>
    <PMID>8691185</PMID>
  </reference>
  <reference>
    <citation>Linskey ME, Segal R. Median nerve injury from local steroid injection in carpal tunnel syndrome. Neurosurgery. 1990 Mar;26(3):512-5.</citation>
    <PMID>2320220</PMID>
  </reference>
  <reference>
    <citation>Wang LY, Leong CP, Huang YC, Hung JW, Cheung SM, Pong YP. Best diagnostic criterion in high-resolution ultrasonography for carpal tunnel syndrome. Chang Gung Med J. 2008 Sep-Oct;31(5):469-76.</citation>
    <PMID>19097594</PMID>
  </reference>
  <reference>
    <citation>Mondelli M, Filippou G, Aretini A, Frediani B, Reale F. Ultrasonography before and after surgery in carpal tunnel syndrome and relationship with clinical and electrophysiological findings. A new outcome predictor? Scand J Rheumatol. 2008 May-Jun;37(3):219-24. doi: 10.1080/03009740801914850.</citation>
    <PMID>18465458</PMID>
  </reference>
  <reference>
    <citation>Gelberman RH, Aronson D, Weisman MH. Carpal-tunnel syndrome. Results of a prospective trial of steroid injection and splinting. J Bone Joint Surg Am. 1980 Oct;62(7):1181-4.</citation>
    <PMID>7000789</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2015</study_first_submitted>
  <study_first_submitted_qc>October 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2015</study_first_posted>
  <last_update_submitted>October 12, 2015</last_update_submitted>
  <last_update_submitted_qc>October 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carpal tunnel syndrome</keyword>
  <keyword>local steroid injection</keyword>
  <keyword>sonography</keyword>
  <keyword>sonography-guided</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucocorticoids</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

